U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07209098) titled 'Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure' on Sept. 30.
Brief Summary: The purpose of this prospective, multi-center, propensity-matched coverage with evidence development (CED) study is to assess the impact of cardiac contractility modulation (CCM) on mortality and heart failure hospitalizations in Medicare-eligible patients with heart failure who meet indications for CCM.
Study Start Date: Oct., 2025
Study Type: OBSERVATIONAL
Condition:
Heart Failure and Reduced Ejection Fraction
NYHA Class III Heart Failure
Intervention:
DEVICE: Cardiac Contractility Modulation (CCM)
CCM is a ther...